Trader consensus on Polymarket prices an 84.5% implied probability for no new WHO-designated COVID-19 variant of concern before 2027, driven by the absence of any VOC classifications since Omicron sublineages years ago, amid SARS-CoV-2's shift to endemic circulation. Recent emergence of BA.3.2 ("Cicada"), a highly mutated Omicron descendant designated only as a variant under monitoring on December 5, 2025, has fueled brief attention—spreading to over 30 U.S. states and 33 countries by mid-April 2026—but genomic surveillance shows no evidence of heightened transmissibility, severity, or vaccine evasion beyond low-level immune escape, with U.S. test positivity at 1.8% and 2025-2026 vaccines remaining protective. High population immunity from prior infections and boosters underpins this stability, though ongoing wastewater and global monitoring could flag surprises.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트예
$233,739 거래량
$233,739 거래량
예
$233,739 거래량
$233,739 거래량
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
마켓 개설일: Dec 1, 2025, 4:49 PM ET
Resolver
0x65070BE91...The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Resolver
0x65070BE91...Trader consensus on Polymarket prices an 84.5% implied probability for no new WHO-designated COVID-19 variant of concern before 2027, driven by the absence of any VOC classifications since Omicron sublineages years ago, amid SARS-CoV-2's shift to endemic circulation. Recent emergence of BA.3.2 ("Cicada"), a highly mutated Omicron descendant designated only as a variant under monitoring on December 5, 2025, has fueled brief attention—spreading to over 30 U.S. states and 33 countries by mid-April 2026—but genomic surveillance shows no evidence of heightened transmissibility, severity, or vaccine evasion beyond low-level immune escape, with U.S. test positivity at 1.8% and 2025-2026 vaccines remaining protective. High population immunity from prior infections and boosters underpins this stability, though ongoing wastewater and global monitoring could flag surprises.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트
외부 링크에 주의하세요.
외부 링크에 주의하세요.
자주 묻는 질문